Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT02812134
Impact of Oral Phosphorus Supplements on the 6-month Change in FGF23 Levels in Anorexic Adolescents Suffering From Undernutrition.
Sponsor: Centre Hospitalier Universitaire, Amiens
View on ClinicalTrials.gov
Summary
Fibroblast growth factor 23 (FGF23) is a recently discovered phosphaturic hormone produced by osteocytes. It is involved in phosphate-calcium metabolism (via its phosphaturic action and inhibition of 1,25-OH vitamin D). There are no published studies on the role of FGF23 in undernourished anorexic adolescents taking oral phosphorus supplements.
Key Details
Gender
All
Age Range
11 Years - 17 Years
Study Type
OBSERVATIONAL
Enrollment
30
Start Date
2016-03-26
Completion Date
2017-06-16
Last Updated
2026-05-28
Healthy Volunteers
No
Conditions
Locations (1)
CHU Amiens
Amiens, France